“Prenatal and Postnatal Epigenetic Programming ( PreP and PEP):
Myelomeningocele: Prenatal and Postnatal Treatment and Complications
description
Transcript of Myelomeningocele: Prenatal and Postnatal Treatment and Complications
![Page 1: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/1.jpg)
Myelomeningocele:Prenatal and Postnatal Treatment
and Complications
Alyssa Brzenski
![Page 2: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/2.jpg)
Case
• A 25 year old G1P0 at 18 weeks gestation, with no previous past medical history, was found during routine screening to have a fetus with T12-S1 myelomeningocele(MMC). The fetus, during a detailed prenatal ultrasound, is found to have Arnold-Chiari malformation but no other congenital abnormalities.
![Page 3: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/3.jpg)
What is Spina Bifida?
![Page 4: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/4.jpg)
Varying Neural Tube Defects
![Page 5: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/5.jpg)
Spina Bifida
![Page 6: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/6.jpg)
Basics of MMC
• 3.4:10,000 births• Related to low folate levels, anticonvulsants
(carbamazepine, valproic acid)• Previous child with same partner is a risk
factor
![Page 7: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/7.jpg)
Co-morbidities
• Sensory motor deficits• Bowel and Bladder Incontinence• Arnold Chiari Type II– Caudal displacement of cerebellar vermis, fourth
ventricle, and lower brainstem• Hydrocephalus• Cognitive delay– Lower risk if no VP Shunt needed
![Page 8: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/8.jpg)
Co-morbidities
![Page 9: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/9.jpg)
Latex Allergies
• All patients with MMC are labeled as latex allergic
• High rates due to recurrent procedures including urinary catheterization
• Cross reaction to avocados, banana, passion fruit, kiwi, banana
![Page 10: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/10.jpg)
Management of Myelomeningocele Study
![Page 11: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/11.jpg)
![Page 12: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/12.jpg)
![Page 13: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/13.jpg)
![Page 14: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/14.jpg)
![Page 15: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/15.jpg)
![Page 16: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/16.jpg)
• What treatment would you recommend?• How would you anesthetize the mother and
fetus for the fetal surgery?• What precautions would you take for a post-
natal repair? Anesthetic plan?
![Page 17: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/17.jpg)
Mid-gestational Open Fetal Procedures
• Significant risk to Mom-– Hemorrhage (13% required transfusion)– Infection (9% developed chorioamnionitis)– Pulmonary Edema (28%)– Premature delivery– Uterine Rupture
• No direct benefit to Mom
![Page 18: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/18.jpg)
![Page 19: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/19.jpg)
Maternal Physiology• Physiology of Pregnancy
– Airway/Pulm• Smaller swollen airway• Decreased FRC, Increased Oxygen Consumption• Respiratory Alkalosis
– Cardiac• Decreased SVR• Increased CO• Left Uterine Displacement
– GI• Full Stomach
– MAC• Decreased anesthetic requirements
![Page 20: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/20.jpg)
Fetal Physiology• Cardiac-
– Fetus heart rate dependent– Slowing during the procedure detrimental
• Heme-– Fetal Blood Volume= 120-160 mL/kg – Hgb = 11.5-12.5 g/dL– Fetal synthesis of clotting factors decreased
• Oxygen Delivery– Dependent on placental perfusion
• Thermoregulation– Fetus unable to maintain temperature– Must warm any fluid administered to mom and amniotic fluid replacement
![Page 21: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/21.jpg)
Mid-gestation Fetal Surgery
• Epidural for Mom- post-op pain control• GA for MOM during the procedure with maintence
of Uterine-placental perfusion• Must have profound uterine relaxation- Can use
high inspired volatile (2MAC) +/- nitroprusside• Fetus paralyzed and monitored during surgery• Minimize fluid administration to avoid pulm edema• Mom must receive tocolysis prior to awakening
and will be monitored for pre-term labor
![Page 22: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/22.jpg)
Post-natal MMC Repair
• Infants repaired early after birth• Must be cautious to not injury the neural tissue
during moving or intubation• Routine ASA monitors• Prone position for repair• May or may not receive VP Shunt at the same time• Typically remain intubated as infant should not lie
supine for the first day
![Page 23: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/23.jpg)
VP Shunts have Complications
![Page 24: Myelomeningocele: Prenatal and Postnatal Treatment and Complications](https://reader035.fdocuments.in/reader035/viewer/2022062501/5681642c550346895dd5eeb8/html5/thumbnails/24.jpg)
Sources• Adzick S et al. A Randomized Trial of Prenatal vs Postnatal Repair of Myelomeningocele. New England Journal of Medicine
2011; 364: 993-1004.• Golombeck K et al. Maternal morbidity after maternal-fetal surgery. AM J Obstet Gynecol 2006; 194: 834-9.• Ferschl M et al. Anesthesia for In-utero repair of myelomeningocele. Anesthesiology 2013; 118: 1211-23.